Symbol="EYPT"
AssetType="Common Stock"
Name="Eyepoint Pharmaceuticals Inc"
Description="EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company is headquartered in Watertown, Massachusetts."
CIK="1314102"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="LABORATORY ANALYTICAL INSTRUMENTS"
Address="480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="312490000"
EBITDA="-80353000"
PERatio="None"
PEGRatio="None"
BookValue="2.285"
DividendPerShare="0"
DividendYield="0"
EPS="-2.68"
RevenuePerShareTTM="1.065"
ProfitMargin="-2.574"
OperatingMarginTTM="-2.066"
ReturnOnAssetsTTM="-0.258"
ReturnOnEquityTTM="-0.836"
RevenueTTM="39793000"
GrossProfitTTM="26948000"
DilutedEPSTTM="-2.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.173"
AnalystTargetPrice="31.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.154"
PriceToBookRatio="0.727"
EVToRevenue="0.112"
EVToEBITDA="0.162"
Beta="1.248"
num_52WeekHigh="11.44"
num_52WeekLow="2.19"
num_50DayMovingAverage="6.76"
num_200DayMovingAverage="4.896"
SharesOutstanding="34301900"
DividendDate="2020-12-09"
ExDividendDate="None"
symbol="EYPT"
open="9.33"
high="9.44"
low="8.91"
price="9.20"
volume="620292.00"
latest_trading_day="2023-07-11"
previous_close="9.11"
change="0.09"
change_percent="0.9879%"
aroon_positive_momentum_days="78"
aroon_negative_momentum_days="0"
trend_strength="Strong Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="78"
Volume_recent_avg="703768"
Change_recent_avg="0.03"
Delta_recent_avg="0.57"
Variance_recent_avg="0.29"
Change_ratio_recent_avg="-0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="78"
Aroon_momentum_negative="22"
image_negative_thumbnail_id_1="148"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0028.jpeg"
image_negative_thumbnail_id_2="126"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0050.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="571"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_positive_thumbnail_id_1="985"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0147.jpeg"
image_positive_thumbnail_id_2="1166"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
